Home » Healthcare » Pharmaceuticals » North America Laxatives Market

North America Laxatives Market By Drug Type (Hyperosmotic Laxatives, Bulk-Forming Laxatives, Stool Softeners, Lubricants, Others); By Indication (Chronic Constipation, Irritable Bowel Syndrome (IBS), Others); By End User (Hospitals & Clinics, Research Institutes, Others); By Route of Administration (Oral, Rectal) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2019-2022
Base Year	2023
Forecast Period	2024-2032
North America laxatives market Size 2023	USD 2,595.43 million
North America laxatives market, CAGR	5.15%
North America laxatives market Size 2032	USD 4,118.19 million

Market Overview

The North America laxatives market is projected to grow from USD 2,595.43 million in 2023 to an estimated USD 4,118.19 million by 2032, with a compound annual growth rate (CAGR) of 5.15% from 2024 to 2032. This growth is driven by the increasing prevalence of gastrointestinal disorders, a growing aging population, and the rising awareness regarding digestive health.

Key market drivers include the escalating incidence of chronic constipation and other related gastrointestinal conditions, alongside a surge in health-consciousness among consumers. Additionally, the trend toward self-medication and the accessibility of laxatives without prescription further propel the market. Technological advancements in product formulations and the introduction of herbal and natural laxatives are also gaining traction, driving market growth.

Geographically, the United States dominates the North America laxatives market, owing to its advanced healthcare infrastructure and high consumer awareness. Canada also presents significant growth opportunities due to the rising incidence of digestive disorders. Key players in the market include Bayer AG, GlaxoSmithKline plc, Sanofi S.A., Johnson & Johnson, and Procter & Gamble Co., who continue to focus on expanding their product portfolios and enhancing distribution networks to strengthen their market position.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Market Drivers

Rising Prevalence of Gastrointestinal Disorders

The increasing prevalence of gastrointestinal (GI) disorders is a significant driver of the North America laxatives market. According to the National Institute of Diabetes and Digestive and Kidney Diseases, chronic constipation affects about 16 out of every 100 adults in the United States. The prevalence is even higher in older adults, with nearly a third of adults aged 60 and over reporting constipation symptoms. Nearly half of Americans have experienced GI symptoms that impacted their daily lives. The use of laxatives in adults has increased over the past decade. This rise in GI disorders is attributed to factors such as sedentary lifestyles, poor dietary habits, and an aging population. The Centers for Disease Control and Prevention (CDC) estimates that only about one in ten adults meets the recommended daily intake of dietary fiber, a key factor in maintaining digestive health. These statistics highlight the growing need for effective treatment options, driving the demand for laxatives in the North American market.

Growing Aging Population

The aging population in North America significantly impacts the laxatives market. According to the U.S. Census Bureau, the number of Americans aged 65 and older is projected to nearly double from 52 million in 2018 to 95 million by 2060. The National Institute on Aging reports that constipation affects approximately one-third of adults over 60. A study published in the American Journal of Gastroenterology found that the prevalence of chronic constipation increases with age, affecting up to a quarter of community-dwelling older adults and up to three-quarters of nursing home residents. The Canadian Institute for Health Information reports similar trends, with constipation being one of the most common complaints among older adults. Adults aged 65 and over are more likely to use laxatives regularly compared to younger age groups. These demographic shifts and the higher incidence of constipation in older adults are driving the demand for laxative products tailored to the needs of the elderly population.

Increased Awareness and Consumer Demand for Digestive Health

Growing awareness of digestive health is fueling the North America laxatives market. A survey by the International Food Information Council Foundation found that nearly two-thirds of Americans consider digestive health to be very important to their overall well-being. There is an increase in the use of complementary health approaches for digestive issues, including the use of natural laxatives. Nearly half of Americans have taken action to improve their digestive health in the past year, with many turning to over-the-counter remedies. The Natural Marketing Institute’s Health & Wellness Trends Database shows a growing interest in natural and herbal digestive health products, with sales of natural laxatives increasing steadily. The use of over-the-counter medications for digestive issues, including laxatives, has increased significantly over the past decade. This heightened awareness and proactive approach to digestive health are driving consumer demand for a variety of laxative products in the North American market.

Innovation and Product Development

Innovation and product development are key drivers of growth in the North America laxatives market. Pharmaceutical companies are continuously working to develop new and improved laxatives that are more effective, have fewer side effects, and are easier to use. The demand for better-tasting, more convenient forms of laxatives, such as gummies, powders, and liquids, is increasing, especially among younger consumers and those who have difficulty swallowing pills. Additionally, there is a growing interest in personalized medicine, which is driving the development of targeted laxative products that cater to specific consumer needs, such as laxatives for those with sensitive stomachs or for children. The introduction of combination products, which include multiple active ingredients to address different aspects of digestive health, is also contributing to market growth. For example, some laxatives now combine fiber supplements with stool softeners or stimulant laxatives to provide a more comprehensive solution for constipation. These innovations are not only meeting the evolving needs of consumers but also creating new opportunities for market expansion. Furthermore, advancements in digital health are enabling companies to offer telemedicine consultations and online sales, making it easier for consumers to access laxatives and receive personalized recommendations. This integration of technology into the healthcare system is expected to further drive the growth of the laxatives market in North America.

Market Trends

Shift Towards Natural and Herbal Laxatives

The North America laxatives market is experiencing a significant shift towards natural and herbal laxatives. Consumers are increasingly seeking products perceived as safer and with fewer side effects compared to traditional chemical-based options. This trend is driven by rising health and wellness consciousness, with consumers becoming more aware of medication ingredients and preferring products aligned with a holistic health approach. Natural laxatives containing ingredients like psyllium husk, senna, aloe vera, and prunes are gaining popularity for their gentle yet effective action on the digestive system. These products appeal particularly to consumers preferring plant-based or organic options and those concerned about long-term use of synthetic ingredients. For instance, there is a growing preference for natural remedies across various age groups, with a notable increase in the use of herbal supplements for digestive health. The trend is also fueled by the broader movement towards sustainability and environmental responsibility, as many of these products are marketed as eco-friendly. Consequently, pharmaceutical companies are expanding their portfolios to include natural and herbal laxatives, either through new product development or brand acquisitions specializing in this segment.

Increased Focus on Innovation and Product Diversification

The North America laxatives market is witnessing an increased focus on innovation and product diversification as companies strive to meet evolving consumer needs. Manufacturers are investing in research and development to create new formulations and delivery formats enhancing user convenience and appeal. There’s a growing trend towards developing laxatives in more palatable forms such as gummies, chewable tablets, and flavored powders, particularly popular among younger consumers and those with difficulty swallowing traditional pills. For instance, a significant increase in consumer preference for alternative dosage forms, with a substantial portion of respondents indicating a preference for chewable or liquid laxatives over traditional tablets. The trend towards combination products is gaining momentum, with companies introducing laxatives that include multiple active ingredients to provide comprehensive digestive health solutions. These products may combine fiber with stool softeners, probiotics, or stimulants to address various aspects of constipation and improve overall gut health. Another area of innovation is the development of targeted laxatives designed for specific consumer groups such as children, pregnant women, or individuals with sensitive digestive systems.

Market Restraints and Challenges

Side Effects and Health Concerns

One of the primary restraints in the North America laxatives market is the concern over potential side effects and long-term health risks associated with laxative use. While laxatives are widely used to alleviate constipation, their overuse or misuse can lead to serious health issues such as dehydration, electrolyte imbalances, and dependency, where the body becomes reliant on laxatives to maintain regular bowel movements. For instance, there is a significant portion of laxative users reported experiencing adverse effects, with many unaware of the potential risks of long-term use. This dependency can cause the digestive system to weaken, leading to chronic constipation and other gastrointestinal issues, which require more intensive medical intervention. These health concerns are increasingly recognized by both consumers and healthcare providers, leading to a more cautious approach to laxative use. A substantial number of healthcare professionals are now more hesitant to recommend long-term laxative use due to these concerns. The growing awareness of these risks is causing some consumers to seek alternatives, such as dietary changes or natural remedies, which could limit the growth of the laxatives market.

Market Saturation and Competition

The North America laxatives market faces significant challenges from market saturation and intense competition. The market is crowded with a wide range of products, from over-the-counter options to prescription medications, making it difficult for new entrants to gain a foothold. For instance, consumers in North America have access to an extensive array of laxative products, with many struggling to differentiate between options. Established players dominate the market, and their strong brand recognition, extensive distribution networks, and large marketing budgets create substantial barriers to entry for smaller or newer companies. Furthermore, with the increasing consumer preference for natural and herbal products, traditional laxative brands are under pressure to innovate and differentiate their offerings. A growing trend towards natural remedies for digestive issues, with many respondents expressing a preference for non-pharmaceutical solutions. This competitive environment is challenging for companies that struggle to invest in research and development or adapt to changing consumer preferences. Additionally, the presence of generic alternatives further intensifies the competition, often leading to price wars that can erode profit margins.

Market Segmentation Analysis

By Drug Type

The North America laxatives market is segmented into various types, each addressing specific consumer needs. Hyperosmotic laxatives, such as lactulose and polyethylene glycol, are popular due to their effectiveness in drawing water into the intestines. Bulk-forming laxatives, including psyllium husk and methylcellulose, are well-regarded for their natural origins and ability to increase stool bulk. Stool softeners provide gentler solutions for those with sensitive digestive systems. Lubricant laxatives offer smoother bowel movements by coating the stool and intestinal walls. For instance, over-the-counter laxatives are among the most commonly used medications in the United States. There is a significant portion of adults use laxatives regularly, with bulk-forming and osmotic laxatives being the most frequently chosen types.

By Indications

Chronic constipation is a primary driver of laxative demand, significantly influenced by the aging population and rising sedentary lifestyles. Irritable Bowel Syndrome (IBS), especially the constipation-predominant type (IBS-C), also plays a crucial role in boosting laxative usage. Additionally, the market is supported by other indications such as occasional constipation and various digestive disorders. For instance, there is a substantial portion of the adult population experiences chronic constipation. Furthermore, IBS affects a significant number of Americans, with many patients relying on laxatives as part of their treatment regimen. These findings underscore the importance of laxatives in managing various gastrointestinal conditions.

Segments

Based on Drug Type

Hyperosmotic Laxatives
Bulk-Forming Laxatives
Stool Softeners
Lubricants
Others

Based on Indication

Chronic Constipation
Irritable Bowel Syndrome (IBS)
Others

Based on End User

Hospitals & Clinics
Research Institutes
Others

Based on Route of Administration

Oral
Rectal

Based on Region

United states
Canada

Regional Analysis

United States (75%):

The United States holds the largest share of the North America laxatives market, accounting for approximately 75% of the total market value. This dominance is attributed to several factors, including a well-established healthcare system, high consumer awareness, and a large aging population. For instance, the prevalence of chronic constipation in the U.S. was around 16% of adults, with higher rates among women and older individuals. The prevalence of gastrointestinal disorders, such as chronic constipation and irritable bowel syndrome (IBS), is particularly high in the U.S., driving the demand for both prescription and over-the-counter laxatives. Additionally, the U.S. market benefits from the presence of major pharmaceutical companies that invest heavily in research and development, leading to continuous product innovation and the introduction of new, more effective laxative formulations.

Canada (25%):

Canada accounts for the remaining 25% of the North America laxatives market, with its market share steadily increasing due to several favorable factors. The Canadian healthcare system, known for its accessibility and comprehensive coverage, plays a crucial role in promoting the use of laxatives among the population. For instance, approximately 27% of the population aged 15 and older experienced symptoms of constipation. The aging demographic, similar to that of the United States, is a significant driver of laxative demand in Canada, as older adults are more prone to chronic constipation and other digestive issues. Moreover, there is a growing awareness of digestive health in Canada, supported by government initiatives and educational campaigns that encourage the early diagnosis and treatment of gastrointestinal disorders. The Canadian market is also witnessing a rise in the popularity of natural and over-the-counter laxatives, reflecting a shift in consumer preferences towards safer and more convenient options.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key players

Hoffmann-La Roche Ltd.
Mylan N.V.
Pfizer Inc.
GlaxoSmithKline plc
Novartis AG
Merck & Co., Inc.
Johnson & Johnson Private Limited
Reddy’s Laboratories Ltd.
Fresenius Kabi AG
Abbott
Avrio Health L.P.
Mallinckrodt
Procter & Gamble
Prestige Consumer Healthcare Inc.

Competitive Analysis

The North America laxatives market is highly competitive, with several major pharmaceutical companies vying for market share. Key players such as Hoffmann-La Roche Ltd., Pfizer Inc., GlaxoSmithKline plc, and Johnson & Johnson Private Limited dominate the market due to their extensive product portfolios, strong brand recognition, and widespread distribution networks. These companies continuously invest in research and development to innovate and expand their laxative offerings, catering to the diverse needs of consumers. Additionally, companies like Procter & Gamble and Prestige Consumer Healthcare Inc. are leveraging their consumer health divisions to promote over-the-counter laxatives, appealing to the growing trend of self-medication. The market also sees competition from generics and smaller companies like Avrio Health L.P. and Dr. Reddy’s Laboratories Ltd., which focus on cost-effective solutions. Overall, the competitive landscape is characterized by a mix of innovation, brand loyalty, and strategic marketing efforts aimed at maintaining and growing market share.

Recent Developments

In December 2023, Pfizer completed the acquisition of Seagen, adding a class of antibody-drug conjugates (ADCs) to its portfolio. While not directly related to laxatives, this acquisition strengthens Pfizer’s overall pharmaceutical offerings.

In July 2024, Procter & Gamble reported strong momentum in its business, including growth in its healthcare segment. While no specific laxative product launch was mentioned, the company’s overall performance in the healthcare sector suggests potential developments in this area.

In July 2024, Johnson & Johnson reported a 4.3% increase in second-quarter sales, reaching $22.4 billion. The company also mentioned significant new product pipeline progress, although no specific laxative products were highlighted.

In July 2024, Merck announced its second-quarter financial results, reporting total worldwide sales of $16.1 billion, an increase of 7% from the second quarter of 2023. While no specific laxative-related developments were mentioned, the company’s overall growth and focus on innovation may include advancements in this area.

In December 2023, Lupin Life, an India-based pharmaceutical company, launched Softovac Liquifibre, a 100% Ayurvedic liquid laxative. While not directly related to Abbott, this development indicates ongoing innovation in the laxatives market that may influence other major players.

Market Concentration and Characteristics

The North America laxatives market is characterized by moderate to high market concentration, with a few key players, such as Hoffmann-La Roche Ltd., Pfizer Inc., and Johnson & Johnson Private Limited, holding significant market shares. These leading companies benefit from strong brand recognition, extensive distribution networks, and continuous product innovation, allowing them to maintain their dominant positions. The market is also defined by a diverse range of product offerings, including both over-the-counter and prescription laxatives, catering to various consumer needs. Despite the presence of several established brands, the market remains competitive, with smaller players and generic manufacturers also vying for market share through cost-effective alternatives and niche products, particularly in the natural and herbal laxatives segment. The overall market dynamics are driven by innovation, consumer preferences for self-medication, and the increasing prevalence of gastrointestinal disorders across the region.

Report Coverage

The research report offers an in-depth analysis based on Drug Type, Indication, End User, Route of Administration and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The North America laxatives market is expected to experience steady growth due to increasing prevalence of gastrointestinal disorders and an aging population. This growth will be driven by rising demand for both prescription and over-the-counter laxatives.

Ongoing innovation will play a crucial role, with companies focusing on developing new formulations and delivery methods to enhance effectiveness and consumer convenience. Expect advancements in natural and herbal laxatives to gain prominence.

Increased consumer awareness about digestive health will drive the demand for laxatives. Educational initiatives and health campaigns will further promote the importance of managing constipation and other GI disorders.

The expansion of distribution channels, including online platforms and retail pharmacies, will improve accessibility to laxatives. E-commerce growth will facilitate easier and more convenient purchasing options for consumers.

There will be a notable shift towards natural and herbal laxatives as consumers increasingly seek safer and less synthetic options. This trend will influence product development and market strategies.

Enhanced regulatory scrutiny and approval processes will impact the introduction of new laxative products. Companies will need to navigate stricter guidelines to ensure compliance and market entry.

Advances in personalized medicine will lead to the development of tailored laxative solutions addressing specific consumer needs, including those related to age, health conditions, and preferences.

The competitive landscape will evolve with both established players and new entrants vying for market share. Innovations and strategic partnerships will be key strategies for gaining a competitive edge.

The over-the-counter laxative segment will continue to expand as more consumers opt for self-medication. Convenience and accessibility will drive growth in this segment.

Broader health trends, such as increased focus on gut health and wellness, will positively impact the laxatives market. Companies will leverage these trends to align their product offerings with evolving consumer expectations.

CHAPTER NO. 1 : INTRODUCTION 15

1.1.1. Report Description 15

Purpose of the Report 15

USP & Key Offerings 15

1.1.2. Key Benefits for Stakeholders 15

1.1.3. Target Audience 16

1.1.4. Report Scope 16

CHAPTER NO. 2 : EXECUTIVE SUMMARY 17

2.1. North America Laxatives Market Snapshot 17

2.1.1. North America Laxatives Market, 2018 – 2032 (USD Million) 18

CHAPTER NO. 3 : NORTH AMERICA LAXATIVES MARKET – INDUSTRY ANALYSIS 19

3.1. Introduction 19

3.2. Market Drivers 20

3.2.1. Driving Factor 1 Analysis 20

3.2.2. Driving Factor 2 Analysis 21

3.3. Market Restraints 22

3.3.1. Restraining Factor Analysis 22

3.4. Market Opportunities 23

3.4.1. Market Opportunity Analysis 23

3.5. Porter’s Five Forces Analysis 24

CHAPTER NO. 4 : ANALYSIS COMPETITIVE LANDSCAPE 25

4.1. Company Market Share Analysis – 2023 25

4.1.1. North America Laxatives Market: Company Market Share, by Volume, 2023 25

4.1.2. North America Laxatives Market: Company Market Share, by Revenue, 2023 26

4.1.3. North America Laxatives Market: Top 6 Company Market Share, by Revenue, 2023 26

4.1.4. North America Laxatives Market: Top 3 Company Market Share, by Revenue, 2023 27

4.2. North America Laxatives Market Company Revenue Market Share, 2023 28

4.3. Company Assessment Metrics, 2023 29

4.3.1. Stars 29

4.3.2. Emerging Leaders 29

4.3.3. Pervasive Players 29

4.3.4. Participants 29

4.4. Start-ups /SMEs Assessment Metrics, 2023 29

4.4.1. Progressive Companies 29

4.4.2. Responsive Companies 29

4.4.3. Dynamic Companies 29

4.4.4. Starting Blocks 29

4.5. Strategic Developments 30

4.5.1. Acquisitions & Mergers 30

New Product Launch 30

North America Expansion 30

4.6. Key Players Product Matrix 31

CHAPTER NO. 5 : PESTEL & ADJACENT MARKET ANALYSIS 32

5.1. PESTEL 32

5.1.1. Political Factors 32

5.1.2. Economic Factors 32

5.1.3. Social Factors 32

5.1.4. Technological Factors 32

5.1.5. Environmental Factors 32

5.1.6. Legal Factors 32

5.2. Adjacent Market Analysis 32

CHAPTER NO. 6 : NORTH AMERICA LAXATIVES MARKET – BY DRUG TYPE SEGMENT ANALYSIS 33

6.1. North America Laxatives Market Overview, by Drug Type Segment 33

6.1.1. North America Laxatives Market Revenue Share, By Drug Type, 2023 & 2032 34

6.1.2. North America Laxatives Market Attractiveness Analysis, By Drug Type 35

6.1.3. Incremental Revenue Growth Opportunity, by Drug Type, 2024 – 2032 35

6.1.4. North America Laxatives Market Revenue, By Drug Type, 2018, 2023, 2027 & 2032 36

6.2. Hyperosmotic 37

6.3. Bulk-Forming 38

6.4. Stool Softeners 39

6.5. Lubricants 40

6.6. Others 41

CHAPTER NO. 7 : NORTH AMERICA LAXATIVES MARKET – BY INDICATION SEGMENT ANALYSIS 42

7.1. North America Laxatives Market Overview, by Indication Segment 42

7.1.1. North America Laxatives Market Revenue Share, By Indication, 2023 & 2032 43

7.1.2. North America Laxatives Market Attractiveness Analysis, By Indication 44

7.1.3. Incremental Revenue Growth Opportunity, by Indication, 2024 – 2032 44

7.1.4. North America Laxatives Market Revenue, By Indication, 2018, 2023, 2027 & 2032 45

7.2. Chronic Constipation 46

7.3. Irritable Bowel Syndrome 47

7.4. Others 48

CHAPTER NO. 8 : NORTH AMERICA LAXATIVES MARKET – BY END-USER SEGMENT ANALYSIS 49

8.1. North America Laxatives Market Overview, by End-user Segment 49

8.1.1. North America Laxatives Market Revenue Share, By End-user, 2023 & 2032 50

8.1.2. North America Laxatives Market Attractiveness Analysis, By End-user 51

8.1.3. Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032 51

8.1.4. North America Laxatives Market Revenue, By End-user, 2018, 2023, 2027 & 2032 52

8.2. Hospitals & Clinics 53

8.3. Research Institutes 54

8.4. Others 55

CHAPTER NO. 9 : NORTH AMERICA LAXATIVES MARKET – BY ROUTE OF ADMINISTRATION SEGMENT ANALYSIS 56

9.1. North America Laxatives Market Overview, by Route of Administration Segment 56

9.1.1. North America Laxatives Market Revenue Share, By Route of Administration, 2023 & 2032 57

9.1.2. North America Laxatives Market Attractiveness Analysis, By Route of Administration 58

9.1.3. Incremental Revenue Growth Opportunity, by Route of Administration, 2024 – 2032 58

9.1.4. North America Laxatives Market Revenue, By Route of Administration, 2018, 2023, 2027 & 2032 59

9.2. Oral 60

9.3. Rectal 61

CHAPTER NO. 10 : NORTH AMERICA LAXATIVES MARKET – NORTH AMERICA 62

10.1. North America 62

10.1.1. Key Highlights 62

10.1.2. North America Laxatives Market Revenue, By Country, 2018 – 2023 (USD Million) 63

10.1.3. North America Laxatives Market Revenue, By Drug Type, 2018 – 2023 (USD Million) 64

10.1.4. North America Laxatives Market Revenue, By Indication, 2018 – 2023 (USD Million) 65

10.1.5. North America Laxatives Market Revenue, By End-user, 2018 – 2023 (USD Million) 66

10.1.6. North America Laxatives Market Revenue, By Route of Administration, 2018 – 2023 (USD Million) 67

10.2. U.S. 68

10.3. Canada 68

10.4. Mexico 68

CHAPTER NO. 11 : COMPANY PROFILES 69

11.1. Hoffmann-La Roche Ltd. 69

11.1.1. Company Overview 69

11.1.2. Product Portfolio 69

11.1.3. Swot Analysis 69

11.1.4. Business Strategy 70

11.1.5. Financial Overview 70

11.2. Mylan N.V 71

11.3. Pfizer Inc 71

11.4. GlaxoSmithKline plc 71

11.5. Novartis AG 71

11.6. Merck & Co., Inc. 71

11.7. Johnson & Johnson Private Limited 71

11.8. Reddy’s Laboratories Ltd. 71

11.9. Fresenius Kabi AG 71

11.10. Abbott 71

11.11. Avrio Health L.P 71

11.12. Mallinckrodt 71

11.13. Procter & Gamble 71

11.14. Prestige Consumer Healthcare Inc. 71

CHAPTER NO. 12 : RESEARCH METHODOLOGY 72

12.1. Research Methodology 72

12.1.1. Phase I – Secondary Research 73

12.1.2. Phase II – Data Modeling 73

Company Share Analysis Model 74

Revenue Based Modeling 74

12.1.3. Phase III – Primary Research 75

12.1.4. Research Limitations 76

Assumptions 76

List of Figures

FIG NO. 1. North America Laxatives Market Revenue, 2018 – 2032 (USD Million) 21

FIG NO. 2. Porter’s Five Forces Analysis for North America Laxatives Market 27

FIG NO. 3. Company Share Analysis, 2023 28

FIG NO. 4. Company Share Analysis, 2023 29

FIG NO. 5. Company Share Analysis, 2023 29

FIG NO. 6. Company Share Analysis, 2023 30

FIG NO. 7. North America Laxatives Market – Company Revenue Market Share, 2023 31

FIG NO. 8. North America Laxatives Market Revenue Share, By Drug Type, 2023 & 2032 37

FIG NO. 9. Market Attractiveness Analysis, By Drug Type 38

FIG NO. 10. Incremental Revenue Growth Opportunity by Drug Type, 2024 – 2032 38

FIG NO. 11. North America Laxatives Market Revenue, By Drug Type, 2018, 2023, 2027 & 2032 39

FIG NO. 12. North America Laxatives Market for Hyperosmotic, Revenue (USD Million) 2018 – 2032 40

FIG NO. 13. North America Laxatives Market for Bulk-Forming, Revenue (USD Million) 2018 – 2032 41

FIG NO. 14. North America Laxatives Market for Stool Softeners, Revenue (USD Million) 2018 – 2032 42

FIG NO. 15. North America Laxatives Market for Lubricants, Revenue (USD Million) 2018 – 2032 43

FIG NO. 16. North America Laxatives Market for Others, Revenue (USD Million) 2018 – 2032 44

FIG NO. 17. North America Laxatives Market Revenue Share, By Indication, 2023 & 2032 46

FIG NO. 18. Market Attractiveness Analysis, By Indication 47

FIG NO. 19. Incremental Revenue Growth Opportunity by Indication, 2024 – 2032 47

FIG NO. 20. North America Laxatives Market Revenue, By Indication, 2018, 2023, 2027 & 2032 48

FIG NO. 21. North America Laxatives Market for Chronic Constipation, Revenue (USD Million) 2018 – 2032 49

FIG NO. 22. North America Laxatives Market for Irritable Bowel Syndrome, Revenue (USD Million) 2018 – 2032 50

FIG NO. 23. North America Laxatives Market for Others, Revenue (USD Million) 2018 – 2032 51

FIG NO. 24. North America Laxatives Market Revenue Share, By End-user, 2023 & 2032 53

FIG NO. 25. Market Attractiveness Analysis, By End-user 54

FIG NO. 26. Incremental Revenue Growth Opportunity by End-user, 2024 – 2032 54

FIG NO. 27. North America Laxatives Market Revenue, By End-user, 2018, 2023, 2027 & 2032 55

FIG NO. 28. North America Laxatives Market for Hospitals & Clinics, Revenue (USD Million) 2018 – 2032 56

FIG NO. 29. North America Laxatives Market for Research Institutes, Revenue (USD Million) 2018 – 2032 57

FIG NO. 30. North America Laxatives Market for Others, Revenue (USD Million) 2018 – 2032 58

FIG NO. 31. North America Laxatives Market Revenue Share, By Route of Administration, 2023 & 2032 60

FIG NO. 32. Market Attractiveness Analysis, By Route of Administration 61

FIG NO. 33. Incremental Revenue Growth Opportunity by Route of Administration, 2024 – 2032 61

FIG NO. 34. North America Laxatives Market Revenue, By Route of Administration, 2018, 2023, 2027 & 2032 62

FIG NO. 35. North America Laxatives Market for Oral, Revenue (USD Million) 2018 – 2032 63

FIG NO. 36. North America Laxatives Market for Rectal, Revenue (USD Million) 2018 – 2032 64

FIG NO. 37. North America Laxatives Market Revenue, 2018 – 2032 (USD Million) 65

FIG NO. 38. Research Methodology – Detailed View 75

FIG NO. 39. Research Methodology 76

List of Tables

TABLE NO. 1. : North America Laxatives Market: Snapshot 20

TABLE NO. 2. : Drivers for the North America Laxatives Market: Impact Analysis 23

TABLE NO. 3. : Restraints for the North America Laxatives Market: Impact Analysis 25

TABLE NO. 4. : North America Laxatives Market Revenue, By Country, 2018 – 2023 (USD Million) 66

TABLE NO. 5. : North America Laxatives Market Revenue, By Country, 2024 – 2032 (USD Million) 66

TABLE NO. 6. : North America Laxatives Market Revenue, By Drug Type, 2018 – 2023 (USD Million) 67

TABLE NO. 7. : North America Laxatives Market Revenue, By Drug Type, 2024 – 2032 (USD Million) 67

TABLE NO. 8. : North America Laxatives Market Revenue, By Indication, 2018 – 2023 (USD Million) 68

TABLE NO. 9. : North America Laxatives Market Revenue, By Indication, 2024 – 2032 (USD Million) 68

TABLE NO. 10. : North America Laxatives Market Revenue, By End-user, 2018 – 2023 (USD Million) 69

TABLE NO. 11. : North America Laxatives Market Revenue, By End-user, 2024 – 2032 (USD Million) 69

TABLE NO. 12. : North America Laxatives Market Revenue, By Route of Administration, 2018 – 2023 (USD Million) 70

TABLE NO. 13. : North America Laxatives Market Revenue, By Route of Administration, 2024 – 2032 (USD Million) 70

Frequently Asked Questions:

What is the projected growth rate for the North America laxatives market?

The North America laxatives market is projected to grow from USD 2,595.43 million in 2023 to approximately USD 4,118.19 million by 2032, with a compound annual growth rate (CAGR) of 5.15% from 2024 to 2032.

What factors are driving the growth of the laxatives market in North America?

Growth in the North America laxatives market is driven by the rising prevalence of gastrointestinal disorders, an aging population, increased health awareness, and a trend towards self-medication and natural product formulations.

Which region leads the North America laxatives market?

The United States leads the North America laxatives market due to its advanced healthcare infrastructure and high consumer awareness, while Canada also presents significant growth opportunities due to a rising incidence of digestive disorders.

What are the key drivers of demand for laxatives?

Key drivers include the increasing incidence of chronic constipation and other gastrointestinal conditions, heightened health consciousness, and the growing availability of over-the-counter laxatives.

Who are the major players in the North America laxatives market?

Major players in the North America laxatives market include Bayer AG, GlaxoSmithKline plc, Sanofi S.A., Johnson & Johnson, and Procter & Gamble Co., which focus on expanding their product portfolios and distribution networks.G

Purchase Options

Single User

$3699

Multi User

$4699

Custom Report

$6699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –